summary
Introduced
12/01/2025
12/01/2025
In Committee
02/11/2026
02/11/2026
Crossed Over
Passed
Dead
Introduced Session
Potential new amendment
104th General Assembly
Bill Summary
Amends the Newborn Metabolic Screening Act. Changes the short title of the Act to the Newborn Screening Act. Specifies that, for purposes of the Act, hearing disorders are a genetic, metabolic, or congenital anomaly for which newborns must be screened. Provides that, beginning July 1, 2026, the base fee for newborn screening services shall be $165. Provides that 22% of the base fee must be allocated to the Department of Public Health for the Early Hearing Detection and Intervention Program. Provides that other State and federal funds for expenses related to metabolic, hearing, or congenital disorder screening, follow-up, and treatment programs (rather than only metabolic screening, follow-up, and treatment programs) may also be placed in the Metabolic Screening and Treatment Fund. In provisions concerning the temporary testing of all blood and biological specimens, excludes hearing screenings. Makes conforming and technical changes to the title of the Act, the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois, the Illinois Procurement Code, the Illinois Public Aid Code, and the Genetic Information Privacy Act. Effective immediately.
AI Summary
This bill modifies the Newborn Metabolic Screening Act to expand newborn screening requirements and update related provisions. Specifically, the bill changes the Act's title to the Newborn Screening Act and explicitly includes hearing disorders as a condition that newborns must be screened for, alongside existing genetic, metabolic, and congenital anomalies. Beginning July 1, 2026, the base fee for newborn screening services will increase to $165, with 22% of that fee allocated specifically to the Department of Public Health's Early Hearing Detection and Intervention Program. The bill also allows other state and federal funds related to hearing, metabolic, and congenital disorder screening, follow-up, and treatment programs to be placed in the Metabolic Screening and Treatment Fund. Additionally, the bill makes technical and conforming changes to several related laws, including the Illinois Procurement Code, the Illinois Public Aid Code, and the Genetic Information Privacy Act, to reflect the expanded scope of newborn screening. The bill takes effect immediately upon becoming law.
Committee Categories
Budget and Finance
Sponsors (3)
Last Action
House Committee Amendment No. 1 Referred to Rules Committee (on 02/27/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...